TIRZEPATIDE 15MG
AED 265.00Price
is the highest maintenance dose of a weekly subcutaneous injection used for chronic weight management (Zepbound) and type 2 diabetes (Mounjaro). It acts as a dual GIP and GLP-1 receptor agonist, reducing appetite, enhancing satiety, and improving glycemic control. It is indicated for adults with obesity or weight-related conditions
